2017
DOI: 10.1128/iai.00010-17
|View full text |Cite|
|
Sign up to set email alerts
|

SseK1 and SseK3 Type III Secretion System Effectors Inhibit NF-κB Signaling and Necroptotic Cell Death in Salmonella-Infected Macrophages

Abstract: Within host cells such as macrophages, Salmonella enterica translocates virulence (effector) proteins across its vacuolar membrane via the SPI-2 type III secretion system. Previously, it was shown that when expressed ectopically, the effectors SseK1 and SseK3 inhibit tumor necrosis factor alpha (TNF-α)-induced NF-κB activation. In this study, we show that ectopically expressed SseK1, SseK2, and SseK3 suppress TNF-α-induced, but not Toll-like receptor 4- or interleukin-induced, NF-κB activation. Inhibition requ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

10
111
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 64 publications
(123 citation statements)
references
References 60 publications
10
111
2
Order By: Relevance
“…Absent Absent Related effectors that inhibit NF-κB signalling (Günster, Matthews, Holden, & Thurston, 2017;Kujat Choy et al, 2004;Yang et al, 2015). (Geddes, Worley, Niemann, & Heffron, 2005;Odendall et al, 2012;Poh et al, 2008) PipB SPI-5 STM1088 t1830 (STY1117) SPA1762 Localizes to SCVs and Sifs (Knodler et al, 2003).…”
Section: Stm4157mentioning
confidence: 99%
“…Absent Absent Related effectors that inhibit NF-κB signalling (Günster, Matthews, Holden, & Thurston, 2017;Kujat Choy et al, 2004;Yang et al, 2015). (Geddes, Worley, Niemann, & Heffron, 2005;Odendall et al, 2012;Poh et al, 2008) PipB SPI-5 STM1088 t1830 (STY1117) SPA1762 Localizes to SCVs and Sifs (Knodler et al, 2003).…”
Section: Stm4157mentioning
confidence: 99%
“…A recent report provides evidence that SseK1 and SseK3, but not SseK2, also function as Arg-GlcNAc glycosyltransferases [9]. Mutation of a conserved DxD catalytic motif within SseK1 and SseK3 abrogates their glycosyltransferase activity [9], consistent with findings for NleB1 [7, 8]. These studies describing catalytically important regions of the glycosyltransferases provide opportunities to better understand the function of these novel enzymes [10].…”
Section: Introductionmentioning
confidence: 54%
“…SseK family members show high sequence similarity to NleB1, a T3SS effector protein from enteropathogenic Escherichia coli (EPEC), which functions as an arginine glycosyltransferase and catalyses the addition of N -acetylglucosamine (GlcNAc) to arginine residues of the mammalian signaling adaptors FADD and TRADD, a modification termed Arg-GlcNAcylation [7, 8]. A recent report provides evidence that SseK1 and SseK3, but not SseK2, also function as Arg-GlcNAc glycosyltransferases [9]. Mutation of a conserved DxD catalytic motif within SseK1 and SseK3 abrogates their glycosyltransferase activity [9], consistent with findings for NleB1 [7, 8].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations